IL17D
IL17C
IL17C is a member of the interleukin 17 (IL-17) cytokine family, which plays a crucial role in the immune system, particularly in the inflammatory response and host defense mechanisms. IL17C is distinct from other IL-17 family members due to its unique expression patterns and functions.
Structure and Expression[edit]
IL17C is a protein encoded by the IL17C gene located on chromosome 16 in humans. The IL-17 cytokine family consists of six members: IL-17A, IL-17B, IL-17C, IL-17D, IL-17E (also known as IL-25), and IL-17F. IL17C is primarily expressed in epithelial cells, including those in the skin, lungs, and gastrointestinal tract.
Function[edit]
IL17C plays a pivotal role in the innate immune response. Unlike other IL-17 family members, which are often produced by T cells, IL17C is produced by epithelial cells in response to bacterial and fungal infections. It acts in an autocrine and paracrine manner to stimulate the production of antimicrobial peptides and pro-inflammatory cytokines, thereby enhancing the barrier function of epithelial tissues.
IL17C signals through a receptor complex composed of IL-17RE and IL-17RA, leading to the activation of downstream signaling pathways such as NF-κB and MAPK. This signaling cascade results in the upregulation of genes involved in inflammation and host defense.
Role in Disease[edit]
IL17C has been implicated in various inflammatory diseases, including psoriasis, inflammatory bowel disease (IBD), and chronic obstructive pulmonary disease (COPD). In psoriasis, IL17C contributes to the inflammatory milieu by promoting the expression of cytokines and chemokines that recruit immune cells to the skin. In IBD, IL17C is involved in maintaining the integrity of the intestinal barrier and modulating the immune response to gut microbiota.
Therapeutic Potential[edit]
Given its role in inflammation and epithelial defense, IL17C is a potential target for therapeutic intervention in inflammatory diseases. Modulating IL17C activity could help in controlling excessive inflammation and restoring tissue homeostasis.
Research Directions[edit]
Ongoing research is focused on understanding the precise mechanisms by which IL17C regulates immune responses and its interactions with other cytokines and immune cells. Studies are also exploring the development of IL17C inhibitors or modulators as potential treatments for inflammatory diseases.
Also see[edit]
- Interleukin 17 family
- Cytokine
- Psoriasis
- Inflammatory bowel disease
- Chronic obstructive pulmonary disease
| Cell signaling: cytokines | ||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| Immunology | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
This immunology-related article is a stub.
|
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian